Over the years, there has been a rapid increase in the number of cases of liver cancer, especially hepatocellular carcinoma (HCC). With these rising cases, diverse notions have come up concerning the treatment and which direction the field should take. To ensure a coherent standpoint concerning liver cancer treatment and its patients, a broad representation drawn from the Asia-Pacific region including its national and international experts have come together to lay a bridge and form a consensus among them. We plan to invite renowned experts from all over the world to have in-depth discussions about clinical experiences and share knowledge, and problems associated with liver cancer treatment. Therefore, we envision a succesful meeting with a deep commitment to contribute to liver cancer treatment not only in the Asia-Pacific region but also globally in the long run.